Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.

Thrombosis and haemostasis - 1 Jun 2015

Prandoni Paolo, Barbar Sofia, Milan Marta, Campello Elena, Spiezia Luca, Piovella Chiara, Pesavento Raffaele

Abstract excerpt

Once anticoagulation is stopped, the risk of recurrent venous thromboembolism (VTE) over years after a first episode is consistently around 30%. This risk is higher in patients with unprovoked than in those with (transient) provoked VTE, and among the latter in patients with medical than in those with surgical risk factors. Baseline parameters that have been found to be related to the risk of recurrent VTE are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Tests
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnostic Imaging

Share to Hemorrhage

Share to Patient Selection

Share to Pulmonary Embolism

Share to Thrombophilia

Share to Venous Thromboembolism

Source

Identifiers

PMID: 25119194
DOI: 10.1160/TH14-04-0396

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.PMID 25119194Read ↗

Update on recognition and management of patients with acquired or inherited hypercoagulability.Semantic proximity Read ↗

Hypercoagulability in venous and arterial thrombosis.Semantic proximity Read ↗

Novel risk factors for venous thromboembolism.Semantic proximity Read ↗

Progress in the research on venous thromboembolism.Semantic proximity Read ↗

Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.Semantic proximity Read ↗

Direct Oral Anticoagulants in Patients with Thrombophilia: Challenges in Diagnostic Evaluation and Treatment.Semantic proximity Read ↗

Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.Semantic proximity Read ↗

Role of thrombophilia in deciding on the duration of anticoagulation.Semantic proximity Read ↗

[Deep vein thrombosis: epidemiology, risk factors and natural history].Semantic proximity Read ↗

Anticoagulation duration in heterozygous factor V Leiden: a decision analysis.Semantic proximity Read ↗

Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT BiobankSemantic proximity Read ↗

Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.